Back
MSCI, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison
Buy
58
MSCI
MSCI, Inc.
Last Price:
$576.56
Seasonality Move:
6.21%
Buy
57
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$25.01
Seasonality Move:
7.92%
Buy
58
MSCI, Inc. (MSCI)
is a Buy
Is MSCI, Inc. a Buy, Sell or Hold?
-
The current MSCI, Inc. [MSCI] share price is $576.64. The Score for MSCI is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
MSCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.40. The Score for APLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MSCI Stock Price Chart
What is MSCI, Inc.'s stock price today?
-
The MSCI, Inc. share price today is $576.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSCI is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $25.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
MSCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 65.44 | Buy |
| Chaikin Money Flow: | 210041 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (544.06 - 564.74) | Buy |
| Bollinger Bands (100): | (547.62 - 574.7) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 64.03 | Buy |
| Chaikin Money Flow: | 582992 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.39 - 24.69) | Buy |
| Bollinger Bands (100): | (21.32 - 27.08) | Buy |
MSCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 559.22 | Buy |
| 20-day SMA: | 553.18 | Buy |
| 50-day SMA: | 558.53 | Buy |
| 200-day SMA: | 559.32 | Buy |
| 8-day EMA: | 561.33 | Buy |
| 20-day EMA: | 557.07 | Buy |
| 50-day EMA: | 558.64 | Buy |
| 200-day EMA: | 561.8 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.97 | Buy |
| 20-day SMA: | 23.25 | Buy |
| 50-day SMA: | 23.11 | Buy |
| 200-day SMA: | 21.91 | Buy |
| 8-day EMA: | 24.72 | Buy |
| 20-day EMA: | 23.69 | Buy |
| 50-day EMA: | 23.2 | Buy |
| 200-day EMA: | 24.29 | Buy |
MSCI, Inc. Earnings Growth & MSCI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.16 per share, and an increase next year of $2.18 per share.
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.44 per share.
MSCI, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||